Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in Europe in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
28 companies reporting in the next 90 days. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Monday, Sep 21 · in 25 days · 2 companies | |||||
| ABVX.PA | ABIVAX Société Anonyme | Rare disease | $10.21B | −5.63% | |
| 2X1.DE | ABIVAX Société Anonyme | Rare disease | — | −6.77% | |
| Thursday, Sep 24 · in 28 days · 1 company | |||||
| 0AB6.L | Hyloris Pharmaceuticals SA | Rare disease | $185.32M | −1.79% | |
| Tuesday, Sep 29 · in 33 days · 2 companies | |||||
| GNFT.PA | Genfit S.A. | Rare disease | $830.56M | ||
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| +5.30% |
| XUP.DE | Genfit S.A. | Rare disease | $258.22M | −1.81% |
| Thursday, Oct 22 · in 56 days · 1 company | |||||
| 1AE.DE | argenx SE | Rare disease | — | +15.89% | |
| Monday, Oct 26 · in 60 days · 1 company | |||||
| 0HNC.L | BioMarin Pharmaceutical Inc. | Rare disease | $9.93B | +0.05% | |
| Wednesday, Oct 28 · in 62 days · 2 companies | |||||
| DBV.PA | DBV Technologies S.A. | Rare disease | $901.25M | +5.42% | |
| DBV.DE | DBV Technologies S.A. | Rare disease | — | +12.83% | |
| Thursday, Oct 29 · in 63 days · 4 companies | |||||
| 0HD2.L | Alnylam Pharmaceuticals, Inc. | Rare disease | $35.05B | +0.67% | |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | Rare disease | $32.28B | −19.59% | |
| 0JAV.L | Insmed Incorporated | Rare disease | $12.89B | +0.43% | |
| 0HB0.L | Agios Pharmaceuticals, Inc. | Rare disease | $1.19B | +0.18% | |
| Monday, Nov 2 · in 67 days · 2 companies | |||||
| VX1.DE | Vertex Pharmaceuticals Incorporated | Rare disease | $139.82B | +10.21% | |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | Rare disease | $112.52B | +0.13% | |
| Tuesday, Nov 3 · in 68 days · 1 company | |||||
| 0LIF.L | Ultragenyx Pharmaceutical Inc. | Rare disease | $1.40B | +1.39% | |
| Wednesday, Nov 4 · in 69 days · 2 companies | |||||
| 0L35.L | Sarepta Therapeutics, Inc. | Rare disease | $1.69B | +1.60% | |
| 0L49.L | SCYNEXIS, Inc. | Rare disease | — | +15.50% | |
| Thursday, Nov 5 · in 70 days · 4 companies | |||||
| CAMX.ST | Camurus AB (publ) | Rare disease | $3.79B | −1.68% | |
| 0H8T.L | Aclaris Therapeutics, Inc. | Rare disease | $122.82M | −6.69% | |
| 0A8E.L | Xeris Biopharma Holdings, Inc. | Rare disease | — | +0.57% | |
| 0K1R.L | Viridian Therapeutics, Inc. | Rare disease | — | +1.29% | |
| Friday, Nov 6 · in 71 days · 1 company | |||||
| 0ABW.L | Egetis Therapeutics AB (publ) | Rare disease | — | +8.09% | |
| Monday, Nov 9 · in 74 days · 1 company | |||||
| 0A9G.L | Mereo BioPharma Group plc | Rare disease | — | −2.36% | |
| Tuesday, Nov 10 · in 75 days · 2 companies | |||||
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | Rare disease | $12.57B | +2.53% | |
| 0A43.L | Inovio Pharmaceuticals, Inc. | Rare disease | — | +4.35% | |
| Thursday, Nov 12 · in 77 days · 2 companies | |||||
| 0KBU.L | Omeros Corporation | Rare disease | $575.28M | −4.75% | |
| 0UNL.L | Nektar Therapeutics | Rare disease | — | +6.73% | |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.